GlassScriptPhysician profile
Ann Mary John
NPI 1922461219
$958.65
in general payments reported to CMS, 2019-2025
17 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2021: $27.88 · 2022: $39.08 · 2023: $141 · 2024: $94.19 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $363.68 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $123.54 | 2023-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $59.82 | 2022-2023 | Sotyktu |
| Incyte Corporation | $50.99 | 2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $39.80 | 2023-2025 | Odomzo |
| Leo Pharma INC. | $39.18 | 2025 | Anzupgo, Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.00 | 2023-2025 | Jublia, Arazlo, Cabtreo |
| Amgen INC. | $36.99 | 2025 | Otezla |
| Organon LLC | $36.77 | 2025 | |
| Galderma Laboratories, L.P. | $34.92 | 2025 | Aklief |
| Novartis Pharmaceuticals Corporation | $29.04 | 2024 | |
| Kerecis Limited | $25.84 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.41 | 2025 | Spevigo |
| Arcutis Biotherapeutics, INC. | $16.53 | 2025 | Zoryve |
| Almirall LLC | $14.38 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.50 | 2021 | |
| Strata Skin Sciences, INC. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.